JP2020143005A - 通気層 - Google Patents
通気層 Download PDFInfo
- Publication number
- JP2020143005A JP2020143005A JP2019039635A JP2019039635A JP2020143005A JP 2020143005 A JP2020143005 A JP 2020143005A JP 2019039635 A JP2019039635 A JP 2019039635A JP 2019039635 A JP2019039635 A JP 2019039635A JP 2020143005 A JP2020143005 A JP 2020143005A
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- ventilation layer
- layer according
- peroxide
- solid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000009423 ventilation Methods 0.000 title claims abstract description 34
- 239000001257 hydrogen Substances 0.000 claims abstract description 119
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 119
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 114
- 239000000203 mixture Substances 0.000 claims abstract description 48
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 239000000463 material Substances 0.000 claims description 32
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 19
- 239000007787 solid Substances 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 229910000000 metal hydroxide Inorganic materials 0.000 claims description 13
- 150000004692 metal hydroxides Chemical class 0.000 claims description 13
- 239000011973 solid acid Substances 0.000 claims description 13
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 10
- 150000004972 metal peroxides Chemical class 0.000 claims description 10
- 239000001301 oxygen Substances 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- XXQBEVHPUKOQEO-UHFFFAOYSA-N potassium superoxide Chemical compound [K+].[K+].[O-][O-] XXQBEVHPUKOQEO-UHFFFAOYSA-N 0.000 claims description 8
- -1 polypropylene Polymers 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 6
- 239000010408 film Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 229910052987 metal hydride Inorganic materials 0.000 claims description 6
- 150000004681 metal hydrides Chemical class 0.000 claims description 6
- 239000004033 plastic Substances 0.000 claims description 6
- 229920003023 plastic Polymers 0.000 claims description 6
- 239000004343 Calcium peroxide Substances 0.000 claims description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 4
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 claims description 4
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 4
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 4
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 4
- 239000000920 calcium hydroxide Substances 0.000 claims description 4
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 4
- LHJQIRIGXXHNLA-UHFFFAOYSA-N calcium peroxide Chemical compound [Ca+2].[O-][O-] LHJQIRIGXXHNLA-UHFFFAOYSA-N 0.000 claims description 4
- 235000019402 calcium peroxide Nutrition 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 claims description 4
- 239000000347 magnesium hydroxide Substances 0.000 claims description 4
- 229910001862 magnesium hydroxide Inorganic materials 0.000 claims description 4
- 229960004995 magnesium peroxide Drugs 0.000 claims description 4
- 235000006408 oxalic acid Nutrition 0.000 claims description 4
- 235000002949 phytic acid Nutrition 0.000 claims description 4
- 239000000467 phytic acid Substances 0.000 claims description 4
- 229940068041 phytic acid Drugs 0.000 claims description 4
- PFUVRDFDKPNGAV-UHFFFAOYSA-N sodium peroxide Chemical compound [Na+].[Na+].[O-][O-] PFUVRDFDKPNGAV-UHFFFAOYSA-N 0.000 claims description 4
- 229920000247 superabsorbent polymer Polymers 0.000 claims description 4
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 claims description 3
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 239000004743 Polypropylene Substances 0.000 claims description 3
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 claims description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 3
- 239000012190 activator Substances 0.000 claims description 3
- 239000000853 adhesive Substances 0.000 claims description 3
- 230000001070 adhesive effect Effects 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 239000003054 catalyst Substances 0.000 claims description 3
- 239000002131 composite material Substances 0.000 claims description 3
- 208000014617 hemorrhoid Diseases 0.000 claims description 3
- 229910012375 magnesium hydride Inorganic materials 0.000 claims description 3
- 239000004745 nonwoven fabric Substances 0.000 claims description 3
- 235000011837 pasties Nutrition 0.000 claims description 3
- 239000008188 pellet Substances 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 229920001155 polypropylene Polymers 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 claims description 3
- 235000012239 silicon dioxide Nutrition 0.000 claims description 3
- 229910052990 silicon hydride Inorganic materials 0.000 claims description 3
- 239000011863 silicon-based powder Substances 0.000 claims description 3
- 239000010409 thin film Substances 0.000 claims description 3
- 239000003642 reactive oxygen metabolite Substances 0.000 claims description 2
- 238000005984 hydrogenation reaction Methods 0.000 claims 1
- RSHAOIXHUHAZPM-UHFFFAOYSA-N magnesium hydride Chemical compound [MgH2] RSHAOIXHUHAZPM-UHFFFAOYSA-N 0.000 claims 1
- 239000010410 layer Substances 0.000 abstract description 52
- 201000010099 disease Diseases 0.000 abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 14
- 238000006243 chemical reaction Methods 0.000 abstract description 9
- 230000008901 benefit Effects 0.000 abstract description 7
- 239000006227 byproduct Substances 0.000 abstract description 6
- 230000006872 improvement Effects 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 5
- 239000002356 single layer Substances 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 32
- 210000001508 eye Anatomy 0.000 description 16
- 208000027418 Wounds and injury Diseases 0.000 description 13
- 210000000214 mouth Anatomy 0.000 description 13
- 206010052428 Wound Diseases 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 11
- 150000002978 peroxides Chemical group 0.000 description 11
- 239000007789 gas Substances 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 208000012902 Nervous system disease Diseases 0.000 description 5
- 208000025966 Neurological disease Diseases 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 238000001959 radiotherapy Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 150000002431 hydrogen Chemical class 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 235000019606 astringent taste Nutrition 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 230000035622 drinking Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229910004283 SiO 4 Inorganic materials 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 229960002949 fluorouracil Drugs 0.000 description 2
- 230000008821 health effect Effects 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 229910052700 potassium Chemical group 0.000 description 2
- 239000011591 potassium Chemical group 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 229910017090 AlO 2 Inorganic materials 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000002424 anti-apoptotic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 239000011777 magnesium Chemical group 0.000 description 1
- 229910052749 magnesium Chemical group 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E60/00—Enabling technologies; Technologies with a potential or indirect contribution to GHG emissions mitigation
- Y02E60/30—Hydrogen technology
- Y02E60/36—Hydrogen production from non-carbon containing sources, e.g. by water electrolysis
Landscapes
- Respiratory Apparatuses And Protective Means (AREA)
- Corsets Or Brassieres (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
【解決手段】薄層であって、外側は通気せず、内側は通気し、内側の表面に複数の小さい孔があり、単層または多層である薄層11と、前記薄層の中に含まれ、漏れることなく空気中の水分または液体の水を吸収して水素を生成する水素生成組成物と、を含み、前記水素は、前記複数の小さい孔を通過して、皮膚および人体内部に排出されて供給される、通気層1。
【選択図】図1
Description
(1) 安全かつ、便利に使用できる。
タンクパイプラインやプラグインは必要ない。携帯しやすく、組成物は無害で、体に触れた状態で使用できる。
(2) 有害な副産物を生成しない
(3) 皮膚に近いため、吸収されやすい。
(4) 水素の幅広い身体保健用途を提供する。
−優れた拡散力を有し、届く部位に制限がない。
−無毒で、人体に優しい安全な還元剤である。
−優れた酸化防止、抗炎症効果を有する。
−常在菌を改善する。
過酸化物であれば、最初は水と反応することで、水酸化物を生成し、酸素を排出する。反応式は以下の通りである。
2Y2O2+2H2O→4Y(OH)+O2(Yはナトリウム、カリウムである)
2Al+2H2O+X(OH)2=X(AlO2)2+3H2
2Al+2H2O+2Y(OH)=2YAlO2+3H2
H4SiO4+2NaOH=Na2SiO3+3H2
11 薄層
111 小さい孔
12 水素生成組成物
Claims (13)
- 薄層であって、外側は通気せず、内側は通気し、内側の表面に複数の小さい孔があり、単層または多層である薄層と、
前記薄層の中に含まれ、漏れることなく空気中の水分または液体の水を吸収して水素を生成する水素生成組成物と、
を含み、
前記水素は、前記複数の小さい孔を通過して、皮膚および人体内部に排出されて供給される、
通気層。 - 前記薄層の内側の材質は、シリカゲル、不織布、またはプラスチック通気膜である、
請求項1に記載の通気層。 - 前記薄層の外側の材質は、ポリプロピレン、ポリエチレンプラスチック薄膜、アルミニウム膜、または複合膜である、
請求項1に記載の通気層。 - 前記水素生成組成物は、粉末状、またはペレット状である、
請求項1に記載の通気層。 - 前記水素生成組成物は、金属過酸化物、金属水酸化物または金属水素化物、および、アルミニウム粉末またはケイ素粉末を含む、
請求項1に記載の通気層。 - 前記水素生成組成物の重量割合は、金属過酸化物または金属水酸化物:アルミニウム粉末=1:100−100:1、好ましくは1:10−10:1である、
請求項5に記載の通気層。 - 前記金属過酸化物は、過酸化カルシウム、過酸化マグネシウム、過酸化ナトリウム、および過酸化カリウムからなる群より選択される、
請求項5に記載の通気層。 - 前記金属水酸化物は、水酸化カルシウム、水酸化マグネシウム、水酸化ナトリウム、および水酸化カリウムからなる群より選択される、
請求項5に記載の通気層。 - 前記金属水素化物は、水素化マグネシウム、水素化カルシウム、および水素化ケイ素からなる群より選択される、
請求項5に記載の通気層。 - 前記水素生成組成物は、pHが4−9の間になるように固体酸が添加され、
前記固体酸は、固体クエン酸、固体乳酸、固体シュウ酸、固体塩酸、固体フィチン酸および固体ケイ酸からなる群より選択される、
請求項5に記載の通気層。 - 前記水素生成組成物は、さらに、高吸水性ポリマー、活性劑または触媒を含む、
請求項1に記載の通気層。 - 前記薄層は、さらに、酸素及び活性酸素生成単位を含む、
請求項1に記載の通気層。 - 前記通気層は、生活衛生材料中に使用でき、
前記生活衛生材料は、アイマスク、口マスク、顔マスク、パック、ブラジャー、ニプレス、胸部パッド、ナプキン、紙おむつ、サニタリーパッド、創傷被覆材、絆創膏、ガーゼ、および痔疾用パッドを含む、
請求項1に記載の通気層。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019039635A JP6814239B2 (ja) | 2019-03-05 | 2019-03-05 | 通気層 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2019039635A JP6814239B2 (ja) | 2019-03-05 | 2019-03-05 | 通気層 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020143005A true JP2020143005A (ja) | 2020-09-10 |
JP6814239B2 JP6814239B2 (ja) | 2021-01-13 |
Family
ID=72353206
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019039635A Active JP6814239B2 (ja) | 2019-03-05 | 2019-03-05 | 通気層 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6814239B2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021176382A (ja) * | 2020-05-07 | 2021-11-11 | ティーオーツーエム コーポレーション | 気体供給マスク |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014019635A (ja) * | 2012-07-23 | 2014-02-03 | Kracie Home Products Ltd | 水素発生用布および水素発生用紙ならびにそれらの製造方法 |
JP2014084233A (ja) * | 2012-10-19 | 2014-05-12 | Seiji Endo | 水素発生用乾燥シート |
WO2015137242A1 (ja) * | 2014-03-11 | 2015-09-17 | ナチュラン・インターナショナル有限会社 | 衛生用品 |
JP2016137010A (ja) * | 2015-01-26 | 2016-08-04 | 幸信 森 | 水素入り化粧品の収納容器 |
JP2017209209A (ja) * | 2016-05-24 | 2017-11-30 | 東洋アルミニウム株式会社 | フェイスパック、フェイスパック用美容液およびその組み合わせ構造 |
WO2018037818A1 (ja) * | 2016-08-23 | 2018-03-01 | 小林 光 | 水素供給材及びその製造方法、並びに水素供給方法 |
JP2018099645A (ja) * | 2016-12-20 | 2018-06-28 | ロート製薬株式会社 | 気体注入具、気体含有液の製造方法及び気体注入具組立キット |
JP2018104395A (ja) * | 2016-12-28 | 2018-07-05 | フェリック株式会社 | 水素発生組成物 |
JP2018130712A (ja) * | 2017-02-13 | 2018-08-23 | エコモ・インターナショナル株式会社 | 水和物化合物を用いた水素発生剤 |
JP3218013U (ja) * | 2018-07-05 | 2018-09-13 | ゲィリー ツァワーGarry Tsaur | スキンケアマスク |
-
2019
- 2019-03-05 JP JP2019039635A patent/JP6814239B2/ja active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014019635A (ja) * | 2012-07-23 | 2014-02-03 | Kracie Home Products Ltd | 水素発生用布および水素発生用紙ならびにそれらの製造方法 |
JP2014084233A (ja) * | 2012-10-19 | 2014-05-12 | Seiji Endo | 水素発生用乾燥シート |
WO2015137242A1 (ja) * | 2014-03-11 | 2015-09-17 | ナチュラン・インターナショナル有限会社 | 衛生用品 |
JP2016137010A (ja) * | 2015-01-26 | 2016-08-04 | 幸信 森 | 水素入り化粧品の収納容器 |
JP2017209209A (ja) * | 2016-05-24 | 2017-11-30 | 東洋アルミニウム株式会社 | フェイスパック、フェイスパック用美容液およびその組み合わせ構造 |
WO2018037818A1 (ja) * | 2016-08-23 | 2018-03-01 | 小林 光 | 水素供給材及びその製造方法、並びに水素供給方法 |
JP2018099645A (ja) * | 2016-12-20 | 2018-06-28 | ロート製薬株式会社 | 気体注入具、気体含有液の製造方法及び気体注入具組立キット |
JP2018104395A (ja) * | 2016-12-28 | 2018-07-05 | フェリック株式会社 | 水素発生組成物 |
JP2018130712A (ja) * | 2017-02-13 | 2018-08-23 | エコモ・インターナショナル株式会社 | 水和物化合物を用いた水素発生剤 |
JP3218013U (ja) * | 2018-07-05 | 2018-09-13 | ゲィリー ツァワーGarry Tsaur | スキンケアマスク |
Non-Patent Citations (1)
Title |
---|
LUMINESCENCE, vol. 22, JPN6019049569, 2007, pages 575 - 580, ISSN: 0004177167 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2021176382A (ja) * | 2020-05-07 | 2021-11-11 | ティーオーツーエム コーポレーション | 気体供給マスク |
Also Published As
Publication number | Publication date |
---|---|
JP6814239B2 (ja) | 2021-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI720465B (zh) | 微環境氫氣供給透氣層及其用途 | |
CN111481425A (zh) | 微环境氢气供给透气层及外敷袋 | |
KR200493176Y1 (ko) | 위생용품 | |
TWM583850U (zh) | 微環境氫氣供給透氣層及其用途 | |
US11471423B2 (en) | Microenvironmental gas permeable layer capable of supplying hydrogen | |
JP2019194162A (ja) | 肌の酸素供給による美白及び加熱機能を備えた通気性材料 | |
US10695456B2 (en) | Skin-friendly absorbent structure for providing oxygen | |
JP6814239B2 (ja) | 通気層 | |
CN105662727A (zh) | 一种远红外线负氧离子卫生巾 | |
JP7515203B2 (ja) | パンティライナーと月経パッドのシステム | |
TWM592306U (zh) | 一種供給一氧化氮之多層裝置 | |
WO2020151005A1 (zh) | 微环境氢气供给透气层 | |
CN211797230U (zh) | 一种供给一氧化氮的多层装置 | |
TWI750362B (zh) | 一種具有皮膚美白供氧並具加熱功能的透氣材料 | |
CN212522757U (zh) | 一种供气口罩 | |
JP3207724U (ja) | 衛生用品 | |
CN209450911U (zh) | 一种改善及预防上呼吸道感染的耳鼻塞入式装置 | |
TW201730100A (zh) | 一種可局部快速產生氧氣組合物 | |
KR102096166B1 (ko) | 피부 미백, 산소 공급 및 보온을 위한 통기성 소재 | |
TWI816904B (zh) | 一種供給一氧化氮之多層裝置 | |
CN201996744U (zh) | 护养保健型妇女卫生巾 | |
CN201768084U (zh) | 竹炭竹纤维一次性卫生片 | |
CN206934253U (zh) | 医用护理垫 | |
CN110368314A (zh) | 一种具有皮肤美白供氧并具加热功能的透气材料 | |
WO2021068134A1 (zh) | 供给一氧化氮的多层装置 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190305 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191224 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200323 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200714 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20201009 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20201020 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20201020 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20201201 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20201218 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6814239 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |